Future Directions in Screening and Prevention
The next step in DePaolo’s research involves expanding the study to 200 patients to explore whether fecal samples could be used as a substitute for mucosal biopsies. This approach could simplify screening processes and make them more accessible. If successful, such screenings could identify individuals at risk before polyps develop, offering a critical window for intervention and subsequent treatment.
Moreover, understanding the role of gut bacteria in colon cancer development opens up new avenues for prevention and treatment. Targeting specific bacteria or modifying the gut microbiome through dietary changes or probiotics could become part of a full-scale strategy to reduce colorectal cancer incidence. As research continues, it may lead to more personalized and effective approaches to managing colorectal cancer.